Skip to main content
. Author manuscript; available in PMC: 2018 Sep 1.
Published in final edited form as: Cancer Epidemiol Biomarkers Prev. 2017 Sep;26(9):1466–1469. doi: 10.1158/1055-9965.EPI-17-0148

Table 2.

Hazards ratios for the effect of Indigenous American ancestry on primary and secondary outcomes.

Breast Cancer Recurrence Breast Cancer-Specific Mortality All-Cause Mortality Disease Free Survival
Crude HR (95% CI) Adjusted HR¥ (95% CI) Crude HR (95% CI) Adjusted HR¥ (95% CI) Crude HR (95% CI) Adjusted HR¥ (95% CI) Crude HR (95% CI) Adjusted HR¥ (95% CI)

Indigenous American Ancestry* 1.00 (0.86, 1.16) 0.98 (0.84, 1.15) 0.95 (0.77, 1.17) 0.97 (0.78, 1.19) 0.93 (0.80, 1.08) 0.98 (0.83, 1.14) 0.96 (0.85, 1.08) 0.98 (0.87, 1.10)
Age at Diagnosis 0.99 (0.96, 1.00) 1.00 (0.98, 1.03) 1.02 (1.00, 1.04) 1.01 (1.00, 1.03)
AJCC Stage
Stage I–II ref ref ref ref
Stage III–IV 4.01 (2.3, 7.1) 7.35 (3.60, 15.0) 4.61 (2.65, 8.03) 3.65 (2.31, 5.76)
Hormonal Therapy
No ref ref ref ref
Yes 0.56 (0.32, 0.97) 0.49 (0.24, 1.00) 0.39 (0.23, 0.66) 0.57 (0.37, 0.88)
*

Per 10% increase in ancestry

¥

Adjusted for age at diagnosis (years), AJCC stage and hormonal therapy.